Market News AIOpen the app

Cencora shares what happened during its earnings call for the third quarter of 2026.

ResultsRead the original at Benzinga
Good for COR

Cencora reported double-digit operating-profit growth and raised its fiscal 2026 profit-per-share forecast. Share repurchases also helped lift per-share growth, and drug list-price changes remain an issue, but management said its services and distribution reach remain valuable.

COR · Cencora

AI read · Good for COR

The AI's read

The growth in operating profit shows the business improved, not just the share count. Share repurchases also helped lift profit per share, so that gain did not come entirely from business operations. Drug list-price changes are still being worked through, but management said Cencora’s services and distribution reach remain valuable.

Get alerts for COR

Follow Cencora (COR) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for COR
Free on the App Store and Google Play, or on the web.